Evelline Araújo Edson

Biotechnologist from the Federal Rural University of the Semi-arido (2017) and master's student in Pharmacology from the Federal University of Ceará. She did an internship at the Laboratory of Ecology of Microorganisms (LEMIC) as a scientific initiation scholarship holder, developing a project that addressed the biotechnological potential of halophilic microorganisms. Initiated a scholarship to teach the subject of General Microbiology developing laboratory analyzes of microbiology. It is currently part of the research line for prospecting natural marine products with anticancer activity. In general, she has knowledge in biotechnology, microbiology, cancerology and immunology, with experience in prospecting for natural products, manipulation of microorganisms, cell culture and immuno-oncology with an emphasis on immunogenic cell death. Biotechnologist from the Universidade Federal Rural do Semiárido (2017), Master in Pharmacology from the Federal University of Ceará (2021) and PhD student in development and technological innovation in medicines at the Federal University of Ceará. Intern at the Laboratory of Ecology of Microorganisms, a project that addresses the biotechnological potential of halophiles. She was the Scholar for Initiation to Teaching of the Discipline of Microbiology General Practice of Microbiology. She was a master's student in the research line of prospecting marine natural products with anticancer activity. Currently, there is no research project evaluating the toxicity of synthetic peptides in parasite forms for application in Chagas disease. additionally, working at Fundação Oswaldo Cruz - Ceará as innovation analysts and pharmaceutical operations III (2021), being responsible for diagnosis 2 by RT-PCR technique. In general, she has extensive knowledge in biotechnology with a focus on the areas of: microbiology, cancerology, molecular biology and pharmacology.

Biotecnologista pela Universidade Federal Rural do Semiárido (2017), Mestre em Farmacologia pela Universidade Federal do Ceará (2021) e Doutoranda em desenvolvimento e inovação tecnológica em medicamentos pela Universidade Federal do Ceará. Estagiou no Laboratório de Ecologia dos Microrganismos (LEMIC) como bolsista de iniciação científica, desenvolvendo um projeto que abordava o potencial biotecnológico de microrganismos halofílicos. Foi bolsista de iniciação a docência da disciplina de Microbiologia Geral desenvolvendo análises laboratoriais de microbiologia. Foi mestranda na linha de pesquisa de prospecção de produtos naturais marinhos com atividade anticâncer. Atualmente, desenvolve no doutorado um projeto de pesquisa com avaliação da toxicidade de peptídeos sintéticos em formas parasitas para aplicação em doença de chagas. Ademais, atuou na Fundação Oswaldo Cruz - Ceará como analista de inovação e operações farmacêuticas III (2021), sendo responsável por diagnóstico de Sars CoV 2 por técnica de RT-PCR. Em geral, possui vasto conhecimento em biotecnologia com foco nas áreas de: microbiologia, cancerologia, biologia molecular e farmacologia.